4//SEC Filing
MERZOUKI ABDERRAZZAK 4
Accession 0001128732-20-000004
CIK 0001402328other
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 2:39 PM ET
Size
8.3 KB
Accession
0001128732-20-000004
Insider Transaction Report
Form 4
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
- Award
Common Stock
2019-12-19$0.00/sh+1,300,000$1,300→ 3,342,500 total - Award
Common Stock
2019-10-20$0.00/sh+1,100,000$1,100→ 2,042,500 total
Holdings
- 3,668(indirect: Held by Axis Biosciences, Inc. of which Reporting Person is a control person.)
Common Stock
Footnotes (2)
- [F1]The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person.
- [F2]The Indirect Shares Beneficially Owned are reported post effective of the reverse stock splits pursuant to Footnote 1. The Indirect holdings were previously reported as 2,193 post-reverse splits shares being held by 91138107 Quebec, Inc. and 1,475 post-reverse stock splits shares being held by Axis Biosciences, Inc. whereas 91138107 Quebec, Inc. and Axis Biosciences, Inc. are one and the same entity and are reported herein as being held by Axis Biosciences, Inc. of which Reporting Person is a control person.
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeother
Related Parties
1- filerCIK 0001636418
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 2:39 PM ET
- Size
- 8.3 KB